Yi Zhu
- Biochemistry top 0.1%
- Eicosanoids and Hypertension Pharmacology 36
- Cancer Research top 1%
- Cell Biology top 1%
- Hippo pathway signaling and YAP/TAZ 16
-
- Hormonal Regulation and Hypertension 13
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 16
-
- Cholesterol and Lipid Metabolism 18
-
- Peroxisome Proliferator-Activated Receptors 13
-
- Liver Disease Diagnosis and Treatment 13
-
- Inflammatory mediators and NSAID effects 12
Yi Zhu
149 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Biochemistry 1.5k
- Cancer Research 1.1k
- Cell Biology 1.2k
- Endocrinology, Diabetes and Metabolism 1.0k
- Immunology and Allergy 343
Countries citing papers authored by Yi Zhu
This map shows the geographic impact of Yi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhu more than expected).
Fields of papers citing papers by Yi Zhu
This network shows the impact of papers produced by Yi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhu. The network helps show where Yi Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 23 | |
| 7 | 2022 | 17 | |
| 8 | 2021 | 32 | |
| 9 | 2021 | 90 | |
| 10 | 2020 | 80 | |
| 11 | 2020 | 93 | |
| 12 | 2017 | 90 | |
| 13 | 2015 | 24 | |
| 14 | 2015 | 14 | |
| 15 | 2013 | 16 | |
| 16 | 2009 | 33 | |
| 17 | 2009 | 8 | |
| 18 | 2007 | 134 | |
| 19 | 2007 | 13 | |
| 20 | 2005 | 7 |
About Yi Zhu
Yi Zhu is a scholar working on Biochemistry, Immunology and Allergy and Cell Biology, having authored 154 papers that have together received 7.6k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (36 papers), Cholesterol and Lipid Metabolism (18 papers), Hippo pathway signaling and YAP/TAZ (16 papers), Cell Adhesion Molecules Research (16 papers), Hormonal Regulation and Hypertension (13 papers), Peroxisome Proliferator-Activated Receptors (13 papers), Liver Disease Diagnosis and Treatment (13 papers) and Inflammatory mediators and NSAID effects (12 papers). The work is most often cited by research in Biochemistry (1.5k citations), Cancer Research (1.1k citations) and Cell Biology (1.2k citations). Yi Zhu has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Ding Ai, Nanping Wang, Xian Wang, Bruce D. Hammock, Michael B. Stemerman, Tzong‐Shyuan Lee, Xu Zhang, Wei Kong, Jinlong He and Hailing Liao. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.